Jane Street Group, LLC Protalix Bio Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 16, 2021	SELL	$1.31 - $1.87 $140,694 - $200,838	-107,400 Reduced 50.64%	104,700 $139,000
Q2 2021 Aug 16, 2021	BUY	$1.86 - $6.22 $358,980 - $1.2 Million	193,000 Added 1010.47%	212,100 $405,000
Q1 2021 May 18, 2021	BUY	$3.58 - $6.45 $68,378 - $123,195	19,100 New	19,100 $85,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $87.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.